# Menarini-Silicon Biosystems to acquire Cellsearch CTC platform from Janssen Diagnostics

Menarini-Silicon Biosystems has signed an agreement to purchase all assets and business related to the Cellsearch circulating tumor cell system from Janssen Diagnostics for an undisclosed amount. The deal includes a CLIA-certified laboratory in Huntingdon Valley, Pennsylvania.

- Type: Acquisition
- Announced: 2016-12-20
- Where: Huntingdon Valley, Pennsylvania, United States
- Status: announced
- Products: Cellsearch circulating tumor cell system, DEPArray rare-cell detection system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Menarini-Silicon Biosystems](https://endata.com/companies/20890.md) (acquirer)
- [Janssen Diagnostics](https://endata.com/companies/20891.md) (target)

## Sources

- [genomeweb.com](https://www.genomeweb.com/molecular-diagnostics/menarini-silicon-biosystems-acquire-cellsearch-ctc-platform-janssen), 2016-12-20: "Menarini-Silicon Biosystems said today that it has signed an agreement to purchase all the assets and relevant business related to the Cellsearch circulating tumor cell (CTC) system from Janssen Diagnostics for an undisclosed amount."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.